Sandoz Still Trying To Sneak Past Amgen’s Stealth Enbrel Patents

Sandoz appeals dismissal of suit seeking a ruling that its Enbrel biosimilar candidate does not infringe patents Amgen licensed from Roche; judge says complaint is premature until an application is filed.